Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-032821
Filing Date
2024-03-18
Accepted
2024-03-18 16:05:57
Documents
12
Period of Report
2023-11-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A prok-20231110.htm   iXBRL 8-K/A 44127
2 EX-10.2 prok-ex10_2.htm EX-10.2 63991
  Complete submission text file 0000950170-24-032821.txt   246274

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20231110.xsd EX-101.SCH 26750
15 EXTRACTED XBRL INSTANCE DOCUMENT prok-20231110_htm.xml XML 6083
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40560 | Film No.: 24759015
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)